Pattern Bioscience, Inc.
Austin, US · Founded 2014 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
CB
Carey-Ann BurnhamExecutive
NA
Nicolas ArabNamed on SEC filing
JR
Johnson RossNamed on SEC filing
BG
Bryan GammonNamed on SEC filing
OM
Oscar MarxNamed on SEC filing
Board
JG
Junjun GaoBoard director
NN
Nicholas NaclerioBoard director
SM
Scott MendelBoard director
GW
Greg WoodBoard director
PB
Patrick BalthropBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$83.7M disclosed across 5 rounds · 2018–2025
▶$44.2MraisedAug 2025 · 6 investors · BiotechnologyRule 506(b)
▶$44.2MraisedAug 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Junjun GaoDirector
- Scott MendelDirector
- Greg WoodDirector
- Nicholas NaclerioDirector
- Patrick BalthropDirector
- Nicolas ArabExecutive Officer, Director
- Carey-Ann BurnhamExecutive Officer, Director
- Offering amount
- $61.2M
- Amount sold
- $44.2M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
▶$23.5MraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Greg WoodDirector
- Bryan GammonDirector
- Patrick BalthropDirector
- Nicolas ArabExecutive Officer, Director
- Nicholas NaclerioDirector
- Offering amount
- $32M
- Amount sold
- $23.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6MraisedJul 2020 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas NaclerioDirector
- Greg WoodDirector
- Bryan GammonDirector
- Nicolas ArabExecutive Officer, Director, Promoter
- Patrick BalthropDirector
- Offering amount
- $9M
- Amount sold
- $6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.4MraisedOct 2019 · 13 investors · BiotechnologyRule 506(b)
▶$6.4MraisedOct 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicolas ArabExecutive Officer, Director, Promoter
- Ross JohnsonExecutive Officer, Promoter
- Bryan GammonDirector
- Gregory WoodDirector
- Oscar B. Marx IIIDirector
- Patrick J. Balthrop, Sr.Director
- Offering amount
- $7M
- Amount sold
- $6.4M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.5MraisedApr 2018 · 10 investors · BiotechnologyRule 506(b)
▶$3.5MraisedApr 2018 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johnson RossExecutive Officer
- Gregory WoodDirector
- Bryan GammonDirector
- Nicolas ArabExecutive Officer, Director
- Oscar MarxDirector
- Patrick BalthropDirector
- Offering amount
- $4M
- Amount sold
- $3.5M
- Minimum investment
- $25K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Pattern Bioscience, Inc.'s investors?
- Pattern Bioscience, Inc.'s investors include AMR Action Fund, Illumina Innovation, Illumina Ventures.
- How much funding has Pattern Bioscience, Inc. raised?
- Pattern Bioscience, Inc. has disclosed $83.7M raised across 5 rounds.
- Where is Pattern Bioscience, Inc. headquartered?
- Pattern Bioscience, Inc. is headquartered in Austin, US.
